Lurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials

Simple item page
dc.contributor.authorPonce, S.
dc.contributor.authorCalvo, E.
dc.contributor.authorDe Miguel, M. J.
dc.contributor.authorSessa, C.
dc.contributor.authorFlor, M. J.
dc.contributor.authorDrilon, A.
dc.contributor.authorFalcon, A.
dc.contributor.authorSanchez Simon, I.
dc.contributor.authorNunez, R.
dc.contributor.authorLuepke, X. E.
dc.contributor.authorCuevas-Melendez, N.
dc.contributor.authorLopez-Vilarino, J.
dc.contributor.authorFudio, S.
dc.contributor.authorSiguero, M.
dc.contributor.authorCullell-Young, M.
dc.contributor.authorKahatt, C.
dc.contributor.authorZeaiter, A.
dc.contributor.authorPaz-Ares, L.
dc.contributor.authoraffiliation[Ponce, S.] Hosp Univ 12 Octubre, Madrid, Spain
dc.contributor.authoraffiliation[Paz-Ares, L.] Hosp Univ 12 Octubre, Madrid, Spain
dc.contributor.authoraffiliation[Calvo, E.] Hosp Madrid Norte Sanchinarro, Start Madrid Ctr Integral Oncol Clara Campal, Madrid, Spain
dc.contributor.authoraffiliation[De Miguel, M. J.] Hosp Madrid Norte Sanchinarro, Start Madrid Ctr Integral Oncol Clara Campal, Madrid, Spain
dc.contributor.authoraffiliation[Sessa, C.] Osped San Giovanni Bellinzona, Bellinzona, Switzerland
dc.contributor.authoraffiliation[Flor, M. J.] Hosp Univ Virgen Del Rocio, Seville, Spain
dc.contributor.authoraffiliation[Falcon, A.] Hosp Univ Virgen Del Rocio, Seville, Spain
dc.contributor.authoraffiliation[Sanchez Simon, I.] Hosp Univ Virgen Del Rocio, Seville, Spain
dc.contributor.authoraffiliation[Drilon, A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
dc.contributor.authoraffiliation[Nunez, R.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Luepke, X. E.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Cuevas-Melendez, N.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Lopez-Vilarino, J.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Fudio, S.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Siguero, M.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Cullell-Young, M.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Kahatt, C.] Pharmamar SA, Colmenar Viejo, Spain
dc.contributor.authoraffiliation[Zeaiter, A.] Pharmamar SA, Colmenar Viejo, Spain
dc.date.accessioned2025-01-07T15:34:32Z
dc.date.available2025-01-07T15:34:32Z
dc.date.issued2019-10-01
dc.identifier.doi10.1016/j.jtho.2019.08.1758
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086419324414/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27252
dc.identifier.wosID492162204243
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS817-S817
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectSCLC
dc.subjectLurbinectedin
dc.subjectCombination
dc.titleLurbinectedin (L) Combined with Paclitaxel (P) or Irinotecan (I) in Relapsed SCLC. Results from Two Phase Lb Trials
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number14
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía